{"id":"https://openalex.org/W2188689309","doi":null,"title":"ADVERSE EFFECTS OF METFORMIN IN COMBINATION WITH GLIMEPIRIDE AND GLIBENCLAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS","display_name":"ADVERSE EFFECTS OF METFORMIN IN COMBINATION WITH GLIMEPIRIDE AND GLIBENCLAMIDE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS","publication_year":2012,"publication_date":"2012-01-01","ids":{"openalex":"https://openalex.org/W2188689309","mag":"2188689309"},"language":"en","primary_location":{"id":"mag:2188689309","doi":null,"is_oa":false,"landing_page_url":"http://www.ajpcr.com/Vol5Suppl1/786.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5065745602","display_name":"Ingle Pravinkumar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ingle Pravinkumar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5041453163","display_name":"Talele Swati Gokul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Talele Swati Gokul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2059,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.61982655,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9399999976158142},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.996999979019165},{"id":"https://openalex.org/keywords/glimepiride","display_name":"glimepiride","score":0.9980000257492065},{"id":"https://openalex.org/keywords/glibenclamide","display_name":"glibenclamide","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sulfonylureas","display_name":"sulfonylureas","score":0.9850000143051147},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8180000185966492},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.8149999976158142},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.9269999861717224},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8199999928474426},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.6759999990463257},{"id":"https://openalex.org/keywords/insulin-secretion","display_name":"insulin secretion","score":0.824999988079071}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8963602781295776},{"id":"https://openalex.org/C2776307423","wikidata":"https://www.wikidata.org/wiki/Q425027","display_name":"Glimepiride","level":4,"score":0.8862301707267761},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.8826185464859009},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.8595708608627319},{"id":"https://openalex.org/C2910068830","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 Diabetes Mellitus","level":3,"score":0.6640443205833435},{"id":"https://openalex.org/C2778854520","wikidata":"https://www.wikidata.org/wiki/Q418776","display_name":"Sulfonylurea","level":3,"score":0.6004977226257324},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5742506980895996},{"id":"https://openalex.org/C2780473172","wikidata":"https://www.wikidata.org/wiki/Q5572518","display_name":"Glycemic","level":3,"score":0.5701714754104614},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.5412895083427429},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5281980633735657},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.521441638469696},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5106938481330872},{"id":"https://openalex.org/C2777448766","wikidata":"https://www.wikidata.org/wiki/Q290001","display_name":"Gliclazide","level":3,"score":0.4258745312690735},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3636592626571655},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3230630159378052}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2188689309","doi":null,"is_oa":false,"landing_page_url":"http://www.ajpcr.com/Vol5Suppl1/786.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":11,"referenced_works":["https://openalex.org/W1980453186","https://openalex.org/W1993108196","https://openalex.org/W1996873493","https://openalex.org/W2014816693","https://openalex.org/W2015382603","https://openalex.org/W2018075481","https://openalex.org/W2045904850","https://openalex.org/W2046224702","https://openalex.org/W2060472986","https://openalex.org/W2084026283","https://openalex.org/W2116836307"],"related_works":["https://openalex.org/W1968062717","https://openalex.org/W4301463317","https://openalex.org/W1874982603","https://openalex.org/W2768906574","https://openalex.org/W7098264837","https://openalex.org/W4240640165","https://openalex.org/W117543825","https://openalex.org/W7217954978","https://openalex.org/W2176639197","https://openalex.org/W3025681791"],"abstract_inverted_index":{"In":[0],"type":[1,39,94,171,211],"2":[2,40,95,172,212],"diabetes":[3,96,213],"mellitus,":[4],"it":[5],"is":[6,114,137],"considered":[7],"that":[8,140,179],"the":[9,14,36,43,83,100,153],"lowered":[10,15],"insulin":[11,16,28,66],"secretion":[12,29],"and":[13,30,123,155,197],"sensitivity":[17],"cause":[18],"hyperglycaemia.":[19],"Sulfonylureas":[20],"have":[21,31,70],"strong":[22,65],"blood-glucose":[23],"lowering":[24],"effect":[25,201],"by":[26],"stimulating":[27],"been":[32],"widely":[33],"used":[34],"in":[35,108,125,170,189,208],"treatment":[37,90,157,207],"of":[38,45,57,64,91,118],"diabetes.":[41],"However,":[42],"use":[44],"sulfonylureas":[46],"has":[47],"several":[48],"issues":[49,134],"(weight":[50],"gain,":[51],"hypoglycaemia,":[52],"secondary":[53],"failure":[54],"etc.),":[55],"some":[56],"which":[58,69],"may":[59],"be":[60],"due":[61],"to":[62,141,151,159],"stimulation":[63],"secretion.":[67],"Sulfonylurea\u2019s,":[68],"evolved":[71],"through":[72],"two":[73],"generations":[74],"since":[75],"their":[76,121,128],"introduction":[77],"nearly":[78],"many":[79],"years":[80],"ago,":[81],"remain":[82],"most":[84,101],"frequently":[85],"prescribed":[86],"oral":[87],"agents":[88],"for":[89],"patients":[92,209],"with":[93,110,182,210],"mellitus.Sulfonylureas":[97],"also":[98],"represent":[99],"cost":[102],"effective":[103,188],"therapeutic":[104],"option":[105],"alone":[106],"or":[107],"combination":[109,180,206],"drugs":[111],"like":[112],"metformin.There":[113],"an":[115],"enormous":[116],"amount":[117],"data":[119],"concerning":[120],"efficacy":[122],"safety":[124],"humans.":[126],"Despite":[127],"wide":[129],"acceptance,":[130],"however":[131],"certain":[132],"critical":[133],"remain.":[135],"It":[136],"increasingly":[138],"obvious":[139],"achieve":[142],"this":[143],"on":[144],"a":[145],"global":[146],"perspective":[147],"we":[148],"will":[149],"need":[150],"identify":[152],"better":[154],"safer":[156],"strategies":[158],"maintain":[160],"tight":[161],"glycemic":[162,191],"control":[163],"as":[164,166],"well":[165],"lower":[167],"adverse":[168,200],"effects":[169],"diabetic":[173],"patients.":[174],"This":[175],"study":[176],"was":[177,186],"suggesting":[178],"therapy":[181],"metformin":[183,203],"plus":[184,204],"glimepiride":[185],"more":[187],"improving":[190],"control,":[192],"exhibiting":[193],"weight":[194],"neutralizing/reducing":[195],"effects,":[196],"having":[198],"minimum":[199],"than":[202],"glibenclamide":[205],"mellitus.":[214]},"counts_by_year":[{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2025-11-06T04:12:42.849631","created_date":"2016-06-24T00:00:00"}